Bronchopulmonary dysplasia: NHLBI Workshop on the Primary Prevention of Chronic Lung Diseases - Test2 - elhamkhani - TriplyDB

Bronchopulmonary dysplasia: NHLBI Workshop on the Primary Prevention of Chronic Lung Diseases

Bronchopulmonary dysplasia: NHLBI Workshop on the Primary Prevention of Chronic Lung Diseases

http://www.wikidata.org/entity/Q33956836

about

Pathogenesis of bronchopulmonary dysplasia: when inflammation meets organ development Biomarkers for Bronchopulmonary Dysplasia in the Preterm Infant Executive Summary: NHLBI Workshop on the Primary Prevention of Chronic Lung Diseases Defining the Risk and Associated Morbidity and Mortality of Severe Respiratory Syncytial Virus Infection Among Infants with Chronic Lung Disease Stem Cells: Potential Therapy for Neonatal Injury?Drug therapy trials for the prevention of bronchopulmonary dysplasia: current and future targets Early pulmonary vascular disease in preterm infants at risk for bronchopulmonary dysplasia.Impaired pulmonary vascular development in bronchopulmonary dysplasia.Untargeted Metabolomic Analysis of Amniotic Fluid in the Prediction of Preterm Delivery and Bronchopulmonary Dysplasia.Hyperoxia-Induced Proliferative Retinopathy: Early Interruption of Retinal Vascular Development with Severe and Irreversible Neurovascular Disruption.Intratracheal Administration of Budesonide-Surfactant in Prevention of Bronchopulmonary Dysplasia in Very Low Birth Weight Infants: A Systematic Review and Meta-Analysis.The Natural History of Bronchopulmonary Dysplasia: The Case for Primary Prevention.Comparisons and Limitations of Current Definitions of Bronchopulmonary Dysplasia for the Prematurity and Respiratory Outcomes Program Progressive Vascular Functional and Structural Damage in a Bronchopulmonary Dysplasia Model in Preterm Rabbits Exposed to Hyperoxia.Late (≥ 7 days) inhalation corticosteroids to reduce bronchopulmonary dysplasia in preterm infants.Mitochondrial dysfunction in inflammatory responses and cellular senescence: pathogenesis and pharmacological targets for chronic lung diseases.Challenges, priorities and novel therapies for hypoxemic respiratory failure and pulmonary hypertension in the neonate.Should we still use vitamin A to prevent bronchopulmonary dysplasia?Antenatal Determinants of Bronchopulmonary Dysplasia and Late Respiratory Disease in Preterm Infants.Mitochondrial dysfunction in alveolar and white matter developmental failure in premature infants.Emerging Clinical Benefits of New-Generation Fat Emulsions in Preterm Neonates.Mast cells and exosomes in hyperoxia-induced neonatal lung disease.Mid-childhood lung function in a cohort of children with "new bronchopulmonary dysplasia".Interdisciplinary Care of Children with Severe Bronchopulmonary Dysplasia.Endothelial Monocyte-Activating Polypeptide II Mediates Macrophage Migration in the Development of Hyperoxia-Induced Lung Disease of Prematurity.Genomic Insights into Respiratory Outcomes after Preterm Birth.Reply: primary and secondary prevention of chronic obstructive pulmonary disease: where to next?Posttranslational modification of β-catenin is associated with pathogenic fibroblastic changes in bronchopulmonary dysplasia.Effect of Inhaled Nitric Oxide on Survival Without Bronchopulmonary Dysplasia in Preterm Infants: A Randomized Clinical Trial.Mesenchymal Stromal Cell Therapy in Bronchopulmonary Dysplasia: Systematic Review and Meta-Analysis of Preclinical Studies.The Evolution of Bronchopulmonary Dysplasia after 50 Years.Bronchopulmonary dysplasia: A review of pathogenesis and pathophysiology.Oxidative stress diseases unique to the perinatal period: A window into the developing innate immune response.Attenuation of endoplasmic reticulum stress by caffeine ameliorates hyperoxia-induced lung injury.Anti-sFlt-1 Therapy Preserves Lung Alveolar and Vascular Growth in Antenatal Models of BPD.Anti-VEGF Antagonists, a Potential Primary Prevention for Bronchopulmonary Dysplasia?Intermittent hypoxia during recovery from neonatal hyperoxic lung injury causes long-term impairment of alveolar development: A new rat model of BPD.Donor Human Milk Protects against Bronchopulmonary Dysplasia: A Systematic Review and Meta-Analysis.Update on Vitamin E and Its Potential Role in Preventing or Treating Bronchopulmonary Dysplasia.Lung Disease, Oxidative Stress, and Oxygen Requirements in Preterm Infants.

P2860

Q26746072-EBE244FA-B943-4B59-82E1-01888D1899EA Q26750310-7F46F426-2A76-46CF-B326-F639A9465DD3 Q27025807-174641DD-8D65-49D6-B3AB-B898345345F7 Q28067464-B7C348FB-609E-48C0-A848-00DD00FDBBC0 Q28082268-0C2EE8A4-E931-48B6-93E4-52A8F43BAB93 Q33948552-F00E061A-6497-4195-9989-CF8A11B2054F Q34987128-813E2EA2-B6A5-4017-9BCD-55B0A14F216D Q35747991-CA993530-FCF6-4AFE-801C-B995CD2326CE Q36166179-FEBEEC58-9946-4580-AEA9-4AA2071324FE Q36197495-D579E224-6519-4DD6-8FBE-27A3A86521C3 Q36271398-2032374D-ACDB-4DA9-A19D-61B7A3043741 Q36325185-B647206E-FA4F-4C12-816B-CEB261B9DA3A Q36490114-6BB19285-E4E6-4364-85AE-264148502CB0 Q38376401-045BD586-CEA4-4C41-847F-E8CEBE133FAE Q38610849-52925122-EAC7-4962-8922-511440E0C5AE Q38836727-BB6C28DC-61D0-4239-9739-4E1B5DD24F09 Q38844488-E4563127-6D31-4E5A-BAAE-6B7D54D5849A Q38845054-B1FE4A42-CFE4-4BE3-AA69-F938A4080FD0 Q38935495-4EBCF5F5-E7E0-48A1-946B-70705B7ACF75 Q39024447-6A52FB7E-AD14-4E4E-A65C-B5B4F94BD851 Q39106629-3EC56F5C-4AB2-4C2D-8478-A21AF5EF7D16 Q39808263-F62B0219-5E93-4299-A210-A4BD2B960933 Q39851928-1EC0962E-6396-4946-BB91-54C10468BA3A Q41456664-8A8E24F0-ADDB-4E84-9329-8A29EB15D4A6 Q41631319-C376CF0F-F64D-4FAA-A378-5995121CDE06 Q42912162-34D9467A-49E3-402D-9929-34874935CABC Q43111782-BBAC8C78-BB02-4303-AB12-8CDA33D8E91D Q44804063-9F47C071-081D-4D8D-A6FD-6509544D3F28 Q45253800-4D91C130-44D3-4A7C-9B0A-E43D842B795F Q46281533-0D477B1D-6080-40AC-A8FC-F65EC06D994C Q47575157-9A54E990-FB0A-4453-A23F-F068D4D4B862 Q47683682-9C63397C-F439-474A-AF34-4AC6A1ED5B33 Q47940232-C61C70D9-F439-49D2-BED1-71BF9DC8AC3A Q48046975-EF2BE50A-A2F9-4262-ADF7-62406C8E4AA7 Q48560810-5C5CBAA6-25F8-4159-B152-F77210935070 Q49340492-8E6EACED-96FB-4BEF-8A3A-B73606581CD6 Q50300339-8C82DF59-C7C7-4875-A77A-913809B8DCCC Q50422522-AA904AC2-8F4C-4972-A106-E7F6E9A34AFF Q52669201-9B387F55-AC5B-49F1-83FB-0FE1D9E0A114 Q54938096-6AD03AAA-36D4-4510-A5A3-C23DC25B5DA6

P2860

Bronchopulmonary dysplasia: NHLBI Workshop on the Primary Prevention of Chronic Lung Diseases

http://www.wikidata.org/entity/Q33956836

description

2014 nî lūn-bûn

@nan

2014 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Bronchopulmonary dysplasia: NH ...... ntion of Chronic Lung Diseases

@ast

Bronchopulmonary dysplasia: NH ...... ntion of Chronic Lung Diseases

@en

type

label

Bronchopulmonary dysplasia: NH ...... ntion of Chronic Lung Diseases

@ast

Bronchopulmonary dysplasia: NH ...... ntion of Chronic Lung Diseases

@en

prefLabel

Bronchopulmonary dysplasia: NH ...... ntion of Chronic Lung Diseases

@ast

Bronchopulmonary dysplasia: NH ...... ntion of Chronic Lung Diseases

@en

P1433

Q33956836-7F7BD3E3-0DD4-4274-A0CB-5AFC387FA3B2

P1476

Q33956836-149F7E3A-D5B7-4741-8F94-3A51321646BA

P2093

Q33956836-132BFB9A-5810-4543-8468-FD04D665290C

Q33956836-2A91449B-855A-495D-B0EF-583CB4BC5506

Q33956836-652A280A-DC6C-4D81-B2ED-9A43CFA23F77

Q33956836-A31D667C-1291-45B1-9026-4542325F0541

Q33956836-AFA4FC36-E99D-4C31-B9FE-2011B657ADBA

P2860

Q33956836-05D85116-E747-486D-BFAE-51D83B4CEFBB

Q33956836-08175F05-F382-4764-95D5-D1D2A52380F2

Q33956836-0A7495DC-EB6A-489B-AA33-30C861194635

Q33956836-0AB704AC-033A-4B86-8A7E-68FED785114B

Q33956836-0EDC1123-F718-48CB-B055-A82611782FF0

Q33956836-1731FC9B-BD9A-414E-B7F3-7A38A4D72A78

Q33956836-1A7F8018-D0FF-4455-8218-A4F38884C2C8

Q33956836-1CDFF779-5181-415E-BC2D-19F43B680182

Q33956836-1E611E26-164E-46D4-8884-69DEBD899B9F

Q33956836-1FCE099E-82C0-4916-9971-F7873B04452C

P304

Q33956836-B8CCB84D-C4FE-4672-A160-FC3AFB8FD63E

P31

Q33956836-68E60A4B-86C2-4F9E-A7BA-2F663101D206

P356

Q33956836-4DF82715-9920-40AB-9E6D-8432F40A277F

P478

Q33956836-D614BBE1-B51C-446F-95B9-2ADD99CA6639

P50

Q33956836-046952FB-BE8F-4535-A0B2-C3B4FE197886

P577

Q33956836-311DBF52-9ABF-410F-8513-DADB36453AB3

P698

Q33956836-ABD21D3F-6BD5-4A10-82D6-045D3DCDD480

P921

Q33956836-C1225D4C-01AB-463A-A68F-9B46C03EC61D

Q33956836-F6966155-B852-4BCE-9FB7-39E21FD4E916

P932

Q33956836-36A19353-0C0F-47E6-9B00-410DC2FAB313

P356

ANNALSATS.201312-424LD

P1433

Proceedings of the American Thoracic Society

P1476

Bronchopulmonary dysplasia: NH ...... ntion of Chronic Lung Diseases

@en

P2093

Barbara Schmidt

http://www.w3.org/2001/XMLSchema#string

Eduardo Bancalari

http://www.w3.org/2001/XMLSchema#string

Judy L Aschner

http://www.w3.org/2001/XMLSchema#string

Lucky Jain

http://www.w3.org/2001/XMLSchema#string

Steven Abman

http://www.w3.org/2001/XMLSchema#string

P2860

Inositol for respiratory distress syndrome in preterm infants

Vitamin A supplementation to prevent mortality and short- and long-term morbidity in very low birthweight infants

Interventions for promoting smoking cessation during pregnancy

Cysteine, cystine or N-acetylcysteine supplementation in parenterally fed neonates

Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth

Selenium supplementation to prevent short-term morbidity in preterm neonates

Nasal CPAP or intubation at birth for very preterm infants

Caffeine Therapy for Apnea of Prematurity

Early CPAP versus surfactant in extremely preterm infants.

Target ranges of oxygen saturation in extremely preterm infants.

P304

S146-53

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1513/ANNALSATS.201312-424LD

http://www.w3.org/2001/XMLSchema#string

P478

11 Suppl 3

http://www.w3.org/2001/XMLSchema#string

P50

P577

2014-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24754823

http://www.w3.org/2001/XMLSchema#string

P921

bronchopulmonary dysplasia

P932

4112507

http://www.w3.org/2001/XMLSchema#string